Beyond weight loss, GLP-1 therapies have been associated with improvements in: Blood sugar control Cardiovascular outcomes Fatty liver disease Obesity-related conditions such as sleep apnea and joint pain These are meaningful benefits
These GLP-1 agonists (glucagon-like peptide-1 receptor agonists) can be effective, but understanding their potential side effects is crucial before starting treatment
Our main goal is to ensure you feel truly revitalized, deeply nourished, and genuinely energized
In rare cases, patients may experience pancreatitis, gallbladder issues, kidney damage or thyroid tumors
Berberine patches are classified as food supplements, not licensed medicines, meaning they have not undergone MHRA pharmaceutical evaluation for quality, safety, or efficacy
Based on the populations studied in clinical trials to date, retatrutide has been investigated primarily in adults living with obesity defined as a body mass index (BMI) of 30 kg/m or above as well as in those who are overweight (BMI 27 kg/m or above) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidaemia
